Table 2.
FBLN1 level in the TAO patients and GD patients.
Variable | TAO | GD (n = 25) |
P value | ||
---|---|---|---|---|---|
Active TAO (n = 30) |
Inactive TAO (n = 25) |
TAO vs. GD | Active vs. Inactive | ||
FBLN1 level, pg/ml | 1885.42 ± 154.82 | 346.37 ± 112.60 | 129.70 ± 11.25 | <0.01 | <0.01 |
GD Grave’s disease patients without ophthalmopathy, FBLN1 Fibulin-1, P compared by Mann–Whitney test. Significant at p < 0.05.